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Abstract
Background: Fluid resuscitation is a fundamental intervention in patients with hypovolemic shock 
resulting from trauma. Appropriate fluid resuscitation in trauma patients could reduce organ failure, 
until blood components are available, and hemorrhage is controlled. We conducted a systematic review 
and meta-analysis assessing the effect of hypertonic saline/dextran or hypertonic saline for fluid resus-
citation on patient outcomes restricted to adults with hypovolemic shock.
Methods: We conducted a search of electronic information sources, including PubMed, Embase, Web 
of Science, Cochrane library and bibliographic reference lists to identify all randomized controlled trials 
(RCTs) investigating outcomes of crystalloids versus colloids in patients with hypovolemic shock. We 
calculated the risk ratio (RR) or mean difference (MD) of groups using fixed or random-effect models.
Results: Fifteen studies including 3264 patients met our inclusion criteria. Survival to hospital 
discharge rate between research groups varied and amounted to 71.2% in hypertonic saline/dextran 
group vs. 68.4% for isotonic/normotonic fluid (normal saline) solutions (odds ratio [OR] = 1.19; 95% 
confidence interval [CI] 0.97–1.45; I2 = 48%; p = 0.09). 28- to 30-days survival rate for hypertonic 
fluid solutions was 72.8% survivable, while in the case of isotonic fluid (normal saline) — 71.4%  
(OR = 1.13; 95% CI 0.75–1.70; I2 = 43%; p = 0.56).
Conclusions: This systematic review and meta-analysis, which included only evidence from RCTs 
hypertonic saline/dextran or hypertonic saline compared with isotonic fluid did not result in superior 
28- to 30-day survival as well as in survival to hospital discharge. However, patients with hypotension 
who received resuscitation with hypertonic saline/dextran had less overall mortality as patients who 
received conventional fluid. (Cardiol J)
Key words: fluid resuscitation, hypovolemic shock, trauma, injury, hypertonic saline, 
normal saline, treatment, crystalloid, colloid fluid
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Introduction
Fluid resuscitation is a fundamental interven-
tion in patients with hypovolemic shock resulting 
from trauma. The main purpose of undertaking 
fluid therapy is to stabilize post-traumatic circu-
lation disorders [1, 2]. Baroreceptor-mediated, 
catecholamine-induced venoconstriction acts on 
the venous capacitance system to increase venous 
return and maintain cardiac output, moreover the 
renin–angiotensin–aldosterone and adrenocortical 
systems produces an antidiuretic response to retain 
water [3]. The hypovolemic shock caused by acute 
hemorrhage occurs when intravascular volume 
loss exceeds the capacity of these compensatory 
mechanisms, resulting in the compromise of vital 
organ perfusion [4]. 
Advanced trauma life support recommends the 
prehospital assessment of a patient’s circulation 
status and to resuscitate with intravenous fluids in 
patients with obvious hemorrhage or systolic blood 
pressure (SBP) below 90 mmHg [5]. A particularly 
important problem of fluid therapy is observed in 
patients with multi-organ injuries, including those 
affecting the central nervous system, which is ex-
tremely susceptible to osmolality changes. For this 
reason, hypotonic solutions that increase intracer-
ebral water and exacerbate post-traumatic brain 
edema are not recommended in patients treated 
for head injuries [6, 7]. As indicated by Reddy et 
al. [8] most infusion solutions exhibit hypoosmotic 
effects, since only some components of crystalline 
solutions are active in plasma and their osmotic 
coefficient is 0.92. 
Crystalloid is a broad term that can encompass 
many different types of solutions from hypertonic 
normal saline (NS) to lactated Ringer’s solution 
to 5% dextrose and half NS. 0.9% sodium chloride 
(NS) is one of the most frequently administered 
solutions. It is also the basis for the preparation of 
many colloids, including hypertonic saline/dextran, 
human albumins or gelatins.
When infused, crystalloids with a sodium 
concentration close to that of intravascular fluid 
(140 mmol/L) produce a transient increase in in-
travascular volume before equilibrating with the 
extracellular fluid. Crystalloids can be used either 
as resuscitation fluids (to increase or maintain 
intravascular volume) or as maintenance fluids (to 
maintain hydration and basic electrolyte balance) 
in persons unable to tolerate enteral administra-
tion of fluid [9]. As indicated by the meta-analysis 
published by Safiejko et al. [10] hypotensive fluid 
resuscitation significantly reduced the mortality 
of traumatic hemorrhagic shock patients. Rapid 
administration of a large volume will cause hy-
perchloremic metabolic acidosis. This is because 
in the case of a standard 0.9% NaCl strong ion 
difference between 0.9% NaCl fluid solution and 
plasma (respectively 0 vs. 40 mEq/L). Therefore, 
it is important to know the effect of using both 
isotonic vs. hypertonic fluid solutions during fluid 
resuscitation of trauma patients. 
The present study is a systematic review and 
meta-analysis assessing the effect of hypertonic 
saline fluid resuscitation on patient outcomes re-
stricted to adults with hypovolemic shock.
Methods
This review was conducted and presented 
according to Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) 
statement standards [11]. We did not publish 
a prior protocol for this review.
Literature searches
A computerized literature search was con-
ducted from the PubMed, Embase, Web of Sci-
ence, and the Cochrane library data bases from 
their inception to August 20th 2020. In addition to 
the reference lists of the selected articles they 
were hand-searched to identify additional relevant 
reports. Google Scholar and other Internet search 
engines were also used to search for additional 
information.
The search terms comprised the followings: 
(crystalloid* OR normal saline* OR saline OR 
Ringers OR Ringer’s OR Hartmanns OR Hart-
mann’s OR hypertonic OR 7.5% saline OR NaCl 
OR sodium chloride) AND (Emergency medicine 
OR Emergency treatment OR Emergency depart-
ment OR Emergency room OR Emergency medi-
cal service OR EMS OR Hemorrhagic shock OR 
Hypovolemic shock OR trauma).
Selection and exclusion criteria
Two reviewers (K.S. and A.S.) independently 
screened the titles and abstracts of all citations re-
trieved during the literature search based on inclu-
sion criteria. Disagreements were resolved through 
discussion until consensus was reached. Inclusive 
criteria: (a) Research types: randomized con-
trolled trials (RCTs) and quasi-randomized trials; 
(b) Research subjects: human studies involved 
adult patients needing fluid resuscitation were 
involved in the meta-analysis. Also included were 
studies which were in preprint. Observational stud-
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ies, case-control studies, non-trials conducted on 
simulated models, editorials, reviews, guidelines, 
meta-analysis, and theoretical models were ex-
cluded from the review. The search was limited to 
English language studies and adult patients need-
ing fluid resuscitation. The data were recorded 
using Review Manager.
Data extraction
Two authors (K.S. and J.R.L.) independently 
reviewed all identified titles and abstracts against 
the prespecified eligibility criteria using a standard-
ized form piloted before the study. The reviewers 
then independently evaluated the full texts of the 
selected articles, applied the selection criteria to 
them, and compared decisions for all the included 
and excluded studies. Disagreements were re-
solved by discussion with the other authors (J.S.). 
The duplicate publications of the same trial were 
excluded from the present study.
The clinical data were extracted as the follow-
ing: the name of the first author, the year published, 
the country of the author, the types of study design, 
the number of patients, type of fluid infused, and 
follow-up time. The primary outcome herein, was 
survival to hospital discharge or at 28 to 30 days. 
Other mortality periods were also extracted as 
defined by the authors.
Outcome measures
The primary endpoint was short-term sur-
vival (hospital discharge or 28 to 30 days). Sec-
ondary outcomes included long-term mortality 
(≥ 3 months), 24-hour mortality, overall mortality, 
adverse outcome, length of stay in an intensive 
care unit and hospital, laboratory parameters at 
patient admission, the Glasgow Outcome Scale 
Extended score. 
Risk of bias assessment
Two authors independently assessed the 
methodological quality and risk of bias of the in-
cluded articles using the method outlined in the 
Cochrane Collaboration Handbook for Systematic 
Reviews of Interventions [12]. Risk of bias was 
assessed as high, low, and unclear for each of selec-
tion bias: random sequence generation, allocation 
concealment, blinding of participants and person-
nel, blinding of outcome assessment, incomplete 
outcome data, selective reporting, and other biases. 
The review authors’ judgments about each risk of 
bias item are provided in Supplementary Digital 
File 1.
Statistical analysis
All analyses were performed by the Review 
Manager Version 5.4. (The Cochrane Collabora-
tion, Oxford, Copenhagen, Denmark). Dichoto-
mous data were presented as risk ratios using the 
Mantel–Haenszel method. Continuous data were 
presented as means with standard deviations and 
analyzed using the inverse variance. The random-
-effects model was used for I2 > 50%; otherwise, 
the fixed effects model was employed. When 
continuous data were presented as medians with 
ranges, the data were converted for inclusion into 
the meta-analysis using the method described by 
Hozo et al. [13]. Heterogeneity among the stud-
ies was assessed using the Cochran Q test (c2). 
Inconsistency was quantified by calculating I2 and 
was interpreted using the following guide: no het-
erogeneity, I2 = 0–25%; moderate heterogeneity, 
I2 = 25–50%; large heterogeneity, I2 = 50–75%; 
extreme heterogeneity, I2 = 75–100%. Where 
appropriate, subgroup analyses were performed 
based on the study design and methodological 
quality.
Role of the funding source
There was no funding source for this study. 
The corresponding author had full access to all the 
data in the study and had final responsibility for the 
decision to submit for publication.
Results
Study selection
The comprehensive search yielded 1271 po-
tentially relevant articles; after exclusion of du-
plicates and assessment of titles and/or abstracts, 
43 articles were chosen for complete review. Finally, 
15 studies including 3264 patients met our inclu-
sion criteria, published between 1987 and 2011 
[14–28]. Figure 1 shows the flow of studies through 
the review. 
Characteristics of included studies
The studies comprised a total of 3264 partici-
pants, of whom 54.9% were exposed to hypertonic 
saline solutions (Table 1). 
All studies were RCTs. Eight studies were 
conducted in the United States of America [15, 
18–20, 24–26], two in Brazil [27, 28], two in Canada 
[21, 22], one in the United Kingdom [14], and one 
in Australia [17]. One study was multi-county [16]. 
In general, the studies were judged as being of good 
quality. Supplementary Digital File 1 presents 
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Figure 1. Flow diagram showing stages of database searching and study selection as per PRISMA guidelines.
inclusion and exclusion criteria, primary outcome 
as well as 28- to 30-day survival rate with an odds 
ratio (OR) (95% confidence interval [CI]).
Primary endpoint
In summary, 9 studies reported survival to 
hospital discharge including 2081 patients [16, 17, 
21–27]. Survival to hospital discharge rate between 
research groups varied and amounted to 71.2% in 
hypertonic saline/dextran (HSD) group vs. 68.4% 
for isotonic fluid (NS) solutions (OR = 1.19; 95% 
CI 0.97–1.45; I2 = 48%; p = 0.09).
Subgroup analysis is shown in Figure 2. Eight 
studies reported a comparison between HSD and 
control group [16, 21–27]. The differences in 
terms of survival to hospital discharge were not 
significant and were respectively 72.8% vs. 72.3% 
(OR = 1.13; 95% CI 0.89–1.44; I2 = 36%; p = 0.30). 
In turn, 4 studies [16, 17, 25, 27] reported analyzed 
comparison between hypertonic saline and isotonic 
saline (68.8% vs. 68.1%, respectively; OR = 1.10; 
95% CI 0.83–1.44; I2 = 0%; p = 0.51). 
28- to 30-day survival rate was reported by 
5 studies [15, 16, 19, 21, 28]. Pooled analysis 
showed that the use of hypertonic fluid solutions 
was 72.8% survivable, while in the case of isotonic 
fluid (NS) — 71.4% (OR = 1.13; 95% CI 0.75–1.70; 
I2 = 43%; p = 0.56). 
As shown in Figure 3 in the HSD subgroup, 
4 studies indicated that hypertonic/dextran solu-
tions infusion [15, 16, 19, 21] was associated with 
a survival rate of 72.6% and NS with 72.8% (OR 
= 1.06; 95% CI 0.64–1.77; I2 = 56%; p = 0.81). 
Analysis in the subgroup where the infusion of 
hypertonic saline vs. isotonic saline [16, 28] was 
used showed survival at the level of 73.1% vs. 
71.9%, respectively (OR = 1.14; 95% CI 0.71–1.83; 
I2 = 49%; p = 0.59). 
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Table 1. Characteristics of included studies.
Study Country Study  
design




N Age Males N Age Males
Alpar et al. 
2004
UK RCT Patients randomized to receive 
HSD or Hartmann’s. HSD infused 
at a dose of 4 mL/kg or maximum 
250 mL, with further fluid resus-
citation with Hartmann’s or blood 
transfusion. Average volume  
infused: HSD group: 4.5 L,  
Hartmann’s group: 6.5 L
90 34.3 ± 
± 11.3
NS 90 33.5 ± 
± 11
ns




Prehospital resuscitation with  
250 mL either HSD or Ringer’s 
lactate. Additional ongoing resus-
citation with Ringer’s lactate only
















Patients randomized to receive  
a 250-mL bolus of either 7.5% HS, 
7.5% HSD 70 or NS, in prehospi-
tal setting












Patients randomized to receive  
a 250 mL bolus of either 7.5%  
saline or Ringer’s lactate solution










USA RCT Patients randomized to receive  
a 3% NaCl (1028 mOsm/kg,  
4 mL/kg) or lactated Ringer’s  
solution (12 mL/kg)










USA RCT Patients randomized to receive  
a 3% NaCl (1028 mOsm/kg,  
4 mL/kg) or lactated Ringer’s  
solution (12 mL/kg)














Patients randomized to receive 
250 mL either HSD or Ringer’s 
lactate as prehospital  
resuscitation















250 mL of NS or 250 mL of HSD 
in a single dose. If the paramed-
ics failed to obtain an intravenous 
access, the study’s solution could 
be started immediately at the 
arrival to the emergency depart-
ment as long as this occurred 
within 4 h from the injury













Patients randomized to receive  
a single 250-mL bolus of either 
HSD or normal saline. Mean  
(standard deviation) total volume 
in first 24 h; Control group: col-
loid 696 (773) mL, crystalloid 8080 
(2736) mL; HSD group: colloid 
361 (377) mL, crystalloid 7796 
(3189) mL; p = 0.02 and p = 0.75 
between groups for crystalloid 
and colloid respectively












Trauma patient were given 250 mL 
of 7.5 HSD 70 or Ringer’s lactate 
as prehospital resuscitation
83 30.3 ± 
± 6.1
NS 83 32.3 ± 
± 6.1
ns




Trauma patients in prehospital 
transport were given 250 mL of: 
(1) normal saline; (2) 7.5% NaCl 
(HS); (3) 7.5% NaCl in 6% HSD 70
174 31.5 ± 
± 14.5
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Figure 2. Forest plot of survival to hospital discharge rate while using hypertonic fluid solutions versus isotonic fluid 
solutions. The center of each square represents the weighted mean difference for individual trials, and the corre-
sponding horizontal line stands for a 95% confidence interval (CI). The diamonds represent pooled results.
Table 1 (cont.). Characteristics of included studies.
Study Country Study  
design




N Age Males N Age Males




Trauma patients were given  
200 mL or more of: (1) Lactate 
Ringer’s solution, (2) 7.5% hyper-
tonic saline solution, (3) 7.5% HS 
combined with 6% HSD 70, (4) 7.5 
HS combined with 12% HSD 70
149 32 ±  
± 13
NS 45 37 ±  
± 18
ns




Trauma patients were given  
250 mL of HSD (7.5% NaCl/6% 
HSD 70) or 250 mL of normal  
saline (0.9% NaCl)
120 32 ±  
± 10.4







Emergency unit patients received 
either an intravenous bolus infu-
sion of 250 mL of hypertonic/ 
/hypertonic 7.5% NaCl + 6% HSD 
70 or an isotonic 0.9% NaCl (NS) 
solution






Emergency unit patients received 
either an intravenous bolus infu-
sion of 250 mL of hypertonic/ 
/hypertonic 7.5% NaCl + 6% HSD 
70 or an isotonic 0.9% NaCl (IS) 
solution








HS — hypertonic saline; HSD — hypertonic saline/dextran; NS — normotonic/isotonic fluid; ns — not specified; RCT — randomized con-
trolled trial
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Secondary endpoints
The detailed results of the secondary end-
points are presented in Table 2. 24 h survival 
rate in case of hypertonic fluids was 88.6% 
and was higher than with isotonic fluids — 
72.3% (OR = 2.99; 95% CI 2.04–4.39; I2 = 0%; 
p < 0.001). In the case of the 3-month survival 
rate, there was no significant statistical dif-
ference (55.3% vs. 48.2%; OR = 1.33; 95% CI 
0.79–2.23; p = 0.29).
Seven studies [14, 16, 20, 22, 26–28] reported 
overall mortality in the experimental group was 
19.7% compared with NS group — 24.8% (OR 
= 0.76; 95% CI 0.61–0.94; I2 = 33%; p = 0.01). 
Subgroup analysis showed higher total mortality in 
the HSD group (23.3% for hypertonic vs. 17.3% for 
isotonic group; p = 0.01) as well as in the hyper-
tonic saline group (25.9% vs. 23.7%, respectively; 
p = 0.51; Fig. 4).
The use of hypertonic fluid was associated 
with a longer hospital stay than with isotonic fluid 
solutions (mean difference [MD] = 1.45; 95% CI 
0.43–2.46; p = 0.005). Acute respiratory distress 
syndrome-free survival rate at 28 days was re- 
ported in 2 studies. The difference between hy-
persaline and normosaline groups was not statis-
tically significant (OR = 1.10; 95% CI 0.85–1.44; 
p = 0.46). 
The use of hypertonic fluid solutions was as-
sociated with higher SBP at hospital admission 
compared to isotonic fluids (MD = 6.71; 95% CI 
1.75–11.67; I2 = 72%; p = 0.008; Suppl. Digital 
File 1).
Polled analyses illustrated selected laboratory 
parameters are presented in Supplementary 
Digital File 1.
Adverse events
Pooled analysis showed no statistically sig-
nificant incidence of complications between hy-
pertonic vs. isotonic fluids solutions. Detailed 
analysis of particular types of adverse events is 
presented in Table 3. The most frequently observed 
nosocomial infections were pneumonia, urinary 
tract infection, or bloodstream infection. For non-
infectious complications: abdominal compartment 
syndrome, cerebral infarction, or deep vein throm-
bosis. A summary of the injuries related and the 
use of fluid types is presented in Supplementary 
Digital File 1. 
Publication bias
The risk of bias of all the RCTs included in the 
meta-analysis is shown in Supplementary Digital 
File 1. Overall, the included RCTs suggested good 
quality in terms of risk of bias. 
Discussion
This systematic review and meta-analysis 
evaluated data from RCTs of hypertonic fluid so-
lutions (HSD or hypertonic saline) and isotonic 
Figure 3. Forest plot of 28- to 30-days survival rate while using hypertonic fluid solutions versus isotonic fluid solu-
tions. The center of each square represents the weighted mean difference for individual trials, and the corresponding 
horizontal line stands for a 95% confidence interval (CI). The diamonds represent pooled results.
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fluid solutions (0.9% NaCl or lactated Ringer’s 
solution) for fluid resuscitation in fluid with trau-
matic hypovolemic shock, encompassing 15 studies 
and approximately 3264 adult trauma patients. At 
primary timepoints assessed (including at 28- to 
30-days survival rate or survival to hospital dis-
Table 2. Characteristics of outcomes: hypertonic fluid solutions versus isotonic fluid solutions.







Percentage of  
adverse event
Treatment effect  
(hypertonic vs.  
normotonic fluid  
solutions)
OR/MD (95% CI)







HSD 2 575 89.4% 73.8% 2.99 (1.88–4.75) < 0.001 18%
NS 2 332 86.4% 68.6% 3.01 (1.54–5.89) 0.001 23%
Total 4 807 88.6% 72.3% 2.99 (2.04–4.39) < 0.001 0%
28- to 30-day survival
HSD 4 972 72.6% 72.8% 1.06 (0.64–1.77) 0.81 56%
NS 2 844 73.1% 71.9% 1.14 (0.71–1.83) 0.59 49%
Total 5 1440 72.8% 71.4% 1.13 (0.75–1.70) 0.56 54%
Survival to discharge
HSD 8 1511 72.8% 72.3% 1.13 (0.89–1.44) 0.30 36%
NS 4 1026 68.8% 68.1% 1.10 (0.83–1.44) 0.51 0%
Total 9 2081 71.2% 69.4% 1.19 (0.97–1.45) 0.09 48%
Survival at 3 months
HSD – – – – – – –
NS 1 228 55.3% 48.2% 1.33 (0.79–2.23) 0.29 –
Total 1 228 55.3% 48.2% 1.33 (0.79–2.23) 0.29 –
Length of hospital stay (days)
HSD 3 361 – – 1.05 (–1.88–3.98) 0.48 0%
NS 1 222 – – 1.50 (0.42–2.58) 0.007 –
Total 4 583 – – 1.45 (0.43–2.46) 0.005 0%
ARDS-free survival rate to day 28
HSD 2 805 51.8% 54.9% 1.15 (0.84–1.57) 0.39 0%
NS 1 632 66.0% 65.4% 1.03 (0.73–1.43) 0.88 –
Total 2 1061 58.0% 54.9% 1.10 (0.85–1.44) 0.46 6%
Total fluids in first 24-h
HSD 4 1268 – – –1.14 (–2.15––0.13) 0.03 0%
NS 1 632 – – –0.70 (–2.47–1.07) 0.44 –
Total 4 1524 – – –1.07 (–2.03––0.12) 0.03 0%
Hypernatremia (Na > 160 mEq/L) requiring intervention
HSD 1 596 0.9% 1.3% 0.68 (0.13–3.54) 0.65 –
NS 1 632 1.9% 1.3% 1.48 (0.42–5.16) 0.54 –
Total 1 852 1.5% 1.3% 1.11 (0.35–3.52) 0.86 –
Overall mortality
HSD 6 1459 17.3% 23.3% 0.72 (0.55–0.94) 0.01 20%
NS 3 914 23.7% 25.9% 0.90 (0.66–1.23) 0.51 10%
Total 7 1962 19.7% 24.8% 0.76 (0.61–0.94) 0.01 33%
ARDS — acute respiratory distress syndrome; CI — confidence interval; HSD — hypertonic fluid solutions; MD — mean difference; NS — izo-
tonic/norotonic fluid solutions; OR — odds ratio
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charge), treatment with hypertonic fluid solutions 
was associated with a higher rate than treatment 
with isotonic fluid solutions). However, in the 
case of 24-survival rate treatment with hypertonic 
fluid solutions was related to a significantly higher 
survival rate, as well as significantly lower overall 
mortality. 
0.9% sodium chloride solution is a basic crys-
talline fluid used in both pre-hospital and hospital 
care [29]. Due to high chlorine levels in the isotonic 
salt, there is a potential risk of metabolic hyper-
chloremic acidosis [30]. An alternative to 0.9% 
NaCl is Ringer’s lactate, also called Hartman’s 
solution, where the sodium and calcium concen-
tration corresponds to the plasma concentration 
of these ions. However, it is important to note 
that the calcium contained in Ringer’s lactate can 
bind to and interfere with some drugs. Indeed, 
Ringer’s lactate is not free of disadvantages. Its 
main disadvantage is that it binds calcium to cit-
rate anticoagulants in blood products, which can 
lead to clots in the bloodstream. Due to the above, 
Ringer’s lactate is contraindicated as a diluent for 
blood transfusions [31, 32]. Hypertonic solutions, 
on the other hand, result in a slight improvement 
in volume and a rapid restoration of hemodynam-
ics. The present analysis looked at hemodynamic 
parameters, such as SBP, and indicated that the use 
of hypertonic fluid solutions was associated with 
a statistically significant higher SBP than that of 
isotonic solutions (p = 0.008). 
According to laboratory studies, hypertonic 
solutions especially improve the hemodynamics 
of microcirculation. This is due to the recruit-
ment of intra-tissue volume by these fluids, which 
increases the volume of circulating blood and at 
the same time increases blood pressure. Accord-
ing to numerous studies, a 7.5% NaCl solution 
should be administered at 250 mL or 4 mL/kg body 
weight [33]. The same volume of hypertonic fluid 
administered compared to the isotonic solution 
causes a greater increase in the volume of fluid in 
the vascular bed, as this difference comes from the 
intracellular fluid, which penetrates from the cells 
into the extracellular space. Therefore, the use of 
hypertonic solutions should be reflected in the treat-
ment of trauma patients as they allow to restore in-
travascular volume without increasing intravascular 
space [34]. Moreover, the present results showed 
no significant differences in adverse events between 
the treatment of hypertonic fluid solutions compared 
with isotonic solutions. However, it should be noted 
that many studies have not reported adverse events, 
which is a potential source of bias.
Limitations of the study
There are potential limitations in this system-
atic review and meta-analysis. One limitation is to 
Figure 4. Forest plot of overall mortality rate while using hypertonic fluid solutions versus isotonic fluid solutions. The 
center of each square represents the weighted mean difference for individual trials, and the corresponding horizontal 
line stands for a 95% confidence interval (CI). The diamonds represent pooled results.
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Table 3. Characteristics of adverse events between hypertonic fluid solutions versus isotonic fluid  
solutions.


















Pneumonia 4 1695 9.9% 9.8% 0.95  
(0.68–1.31)
0.75 0%
ARDS 1 422 0.0% 0.9% 0.20  
(0.01–4.15)
0.30 –
Blood stream infection 2 1061 7.2% 6.1% 1.18  
(0.72–1.93)
0.51 0%
Urinary tract infection 2 1061 6.1% 7.6% 0.79  
(0.49–1.28)
0.34 0%
Wound infection 2 1061 5.8% 4.0% 1.50  
(0.84–2.67)
0.17 0%
Intra-abdominal abcess 2 631 1.6% 0.3% 3.49  
(0.57–21.54)
0.18 11%
Sinustis 1 209 0.9% 0.0% 2.71  
(0.11–67.69)
0.54 –
Pseudomembranous colitis 1 209 1.0% 0.0% 2.73  
(0.11–67.69)
0.54 –
Line infection 1 209 1.0% 0.0% 2.73  
(0.11–67.69)
0.54 –
Sepsis 1 422 0.0% 1.4% 0.14  
(0.01–2.74)
0.20 –
Other 1 311 3.8% 0.0% 8.27  
(0.47–144.75)
0.15 –




Acute renal failure 3 780 0.8% 1.6% 0.52  
(0.14–1.95)
0.33 0%
Abdominal compartment syndrome 1 209 3.6% 8.1% 0.43  
(0.13–1.47)
0.18 –
Cardiac arrest 2 568 1.0% 1.5% 0.71  
(0.17–2.88)
0.63
Myocardial infarction 3 780 1.0% 2.1% 0.52  
(0.16–1.67)
0.28 0%
Cerebral infarction 2 421 4.3% 2.8% 1.61  
(0.58–4.53)
0.36 0%
Dead bowel 1 359 0.0% 0.6% 0.32  
(0.01–7.79)
0.48 –
Deep vein thrombolysis 1 209 0.9% 7.0% 0.12  
(0.01–1.00)
0.05 –
Pulmonary embolism 2 568 0.3% 1.1% 0.39  
(0.06–2.70)
0.34 0%
Coagulopathy 1 359 0.9% 0.0% 2.73  
(0.11–67.69)
0.54 – 
ARDS — acute respiratory distress syndrome; CI — confidence interval; HS — hypertonic saline; HSD — hypertonic fluid solutions; NS — iso-
tonic/norotonic fluid solutions; OR — odds ratio
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include only studies on the use of fluid therapy in 
patients with hypovolemic shock resulting from 
the injury. However, this was deliberate because 
it is a specific group of patients who require differ-
ent treatment from patients with no hypovolemic 
shock due to the bleeding. The second limitation 
of the study is the fact that over the last years no 
randomized study has been published in the scope 
discussed in the article. With the development 
of medical technology and the creation of new 
guidelines of conduct, the authors believe that 
a multi-center study should be carried out, involv-
ing a large number of patients, which would verify 
the data from previous articles.
Conclusions
This systematic review and meta-analysis, 
which included only evidence from RCTs hyper-
tonic saline/dextran or hypertonic saline compared 
with isotonic fluid did not result in superior 28- to 
30-day survival as well as in survival to hospital 
discharge. However, patients with hypotension 
who received resuscitation with HSD had less 
overall mortality than patients who received con-
ventional fluid. These findings highlight an urgent 
need for further research and guidance for physi-
cians regarding when to administer fluid solutions 
to ensure optimal fluid therapy for the resuscitation 
of hypovolemic shock caused by acute hemorrhage.
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